Hydropersulfides (RSSH) attenuate doxorubicin-induced cardiotoxicity while boosting its anticancer action is a research paper published in Redox Biology (2023). On theSindex it has a DataRank of 0. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 GM145940
National Institutes of Health
Grant: T32 AG058527
National Institutes of Health
Grant: T32 GM080189
National Institute on Aging
Grant: P30AG021334
National Institute on Aging
Grant: R01 HL136918
National Institutes of Health
Grant: 5T32GM080189-12
The Chemistry-Biology Interface Program at Johns Hopkins University
National Institutes of Health
Grant: 5R01HL136918-04
BDNF TrkB- and beta-AR signals in ischemic and non-ischemic cardiomyopathy
National Institutes of Health
Grant: 5T32AG058527-05
Translational Aging Research Training Program
National Institutes of Health
Grant: 3P30AG021334-01S1
Older Americans Independence Center
National Institutes of Health
Grant: 1R01GM145940-01
Mitochondria-Targeted Hydropersulfide Donors to Treat Anthracycline-Induced Cardiotoxicity
Johns Hopkins University
FWCI
5.45
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords